China SXT Pharmaceuticals, Inc. SEC filings SXTC
China SXT Pharmaceuticals, Inc. has 169 filings in SEC EDGAR's recent list, going back to Dec 4, 2017. Its latest annual report, Form 20-F, was filed on Jul 1, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 21, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 21, 2026 |
| 6-K | Current report (foreign issuer) | Oct 9, 2026 | Oct 9, 2026 |
| 424B5 | Prospectus supplement | Oct 9, 2026 | — |
| 6-K | Current report (foreign issuer) | Oct 8, 2026 | Oct 8, 2026 |
| 6-K | Current report (foreign issuer) | Oct 8, 2026 | Oct 8, 2026 |
| EFFECT | Filing | Sep 16, 2026 | — |
| F-3/A | Amendment no. 1 to form f-3 | Aug 28, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 28, 2026 | Aug 28, 2026 |
| 6-K | Current report (foreign issuer) | Jul 24, 2026 | Jul 24, 2026 |
| 424B5 | Prospectus supplement | Jul 24, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 7, 2026 | — |
| 6-K | Current report (foreign issuer) | Jul 6, 2026 | Jul 6, 2026 |
| 20-F | Annual report (foreign issuer) | Jul 1, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | Jun 1, 2026 | Jun 1, 2026 |
| 424B5 | Prospectus supplement | Jun 1, 2026 | — |
| 6-K | Current report (foreign issuer) | May 4, 2026 | May 4, 2026 |
| 424B5 | Prospectus supplement | Apr 9, 2026 | — |
| 6-K | Current report (foreign issuer) | Apr 9, 2026 | Apr 9, 2026 |
| 6-K | Current report (foreign issuer) | Jan 13, 2026 | Jan 13, 2026 |
| 424B5 | Prospectus supplement | Jan 12, 2026 | — |
| 6-K | Current report (foreign issuer) | Dec 31, 2025 | Sep 30, 2025 |
| EFFECT | Filing | Nov 14, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 10, 2025 | — |
| POS AM | Post-effective amendment no. 1 to form f-3 | Nov 10, 2025 | — |
| 20-F | Annual report (foreign issuer) | Jul 31, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Jul 29, 2025 | Jul 29, 2025 |
| 6-K | Current report (foreign issuer) | Jul 15, 2025 | Jul 15, 2025 |
| 6-K | Current report (foreign issuer) | Jun 16, 2025 | Jun 16, 2025 |
| 424B5 | Prospectus supplement | May 19, 2025 | — |
| 6-K | Current report (foreign issuer) | May 13, 2025 | May 13, 2025 |
| 424B5 | Prospectus supplement | May 7, 2025 | — |
| S-8 | Employee stock plan registration | Mar 28, 2025 | — |
| 6-K | Current report (foreign issuer) | Mar 28, 2025 | Sep 30, 2024 |
| 6-K | Current report (foreign issuer) | Mar 19, 2025 | Mar 19, 2025 |
| 6-K | Current report (foreign issuer) | Jan 27, 2025 | Jan 27, 2025 |
| 6-K | Current report (foreign issuer) | Jan 23, 2025 | Jan 23, 2025 |
| EFFECT | Filing | Nov 4, 2024 | — |
| CORRESP | Letter to the SEC | Nov 1, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 30, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 22, 2024 | — |
| 6-K | Current report (foreign issuer) | Oct 15, 2024 | Oct 15, 2024 |
| 20-F | Annual report (foreign issuer) | Aug 13, 2024 | Mar 31, 2024 |
| NT 20-F | Notification of late filing | Jul 31, 2024 | Mar 31, 2024 |
| 6-K | Current report (foreign issuer) | May 14, 2024 | May 14, 2024 |
| 6-K | Current report (foreign issuer) | Apr 5, 2024 | Sep 30, 2023 |
| S-8 | Employee stock plan registration | Jan 11, 2024 | — |
| 20-F | Annual report (foreign issuer) | Jul 31, 2023 | Mar 31, 2023 |
| UPLOAD | Letter from the SEC | Jun 2, 2023 | — |
| 20-F/A | Amended annual report (foreign issuer) | May 19, 2023 | Mar 31, 2022 |
| CORRESP | Letter to the SEC | Apr 13, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2023 | — |
| 424B7 | Filing | Mar 27, 2023 | — |
| 6-K | Current report (foreign issuer) | Mar 23, 2023 | Mar 23, 2023 |
| 6-K | Current report (foreign issuer) | Feb 28, 2023 | Feb 28, 2023 |
| 6-K | Current report (foreign issuer) | Feb 24, 2023 | Sep 30, 2022 |
| 6-K | Current report (foreign issuer) | Dec 23, 2022 | Dec 22, 2022 |
| 6-K | Current report (foreign issuer) | Oct 12, 2022 | Oct 12, 2022 |
| 6-K | Current report (foreign issuer) | Sep 27, 2022 | Sep 27, 2022 |
| 20-F | Annual report (foreign issuer) | Jul 18, 2022 | Mar 31, 2022 |
| 6-K | Current report (foreign issuer) | May 13, 2022 | May 13, 2022 |
| 6-K | Current report (foreign issuer) | May 11, 2022 | May 11, 2022 |
| 6-K | Current report (foreign issuer) | Mar 24, 2022 | Mar 24, 2022 |
| 6-K | Current report (foreign issuer) | Mar 16, 2022 | Mar 16, 2022 |
| 424B5 | Prospectus supplement | Mar 16, 2022 | — |
| S-8 | Employee stock plan registration | Mar 15, 2022 | — |
| 6-K | Current report (foreign issuer) | Feb 9, 2022 | Feb 8, 2022 |
| 6-K | Current report (foreign issuer) | Jan 31, 2022 | Jan 31, 2022 |
| 6-K | Current report (foreign issuer) | Jan 21, 2022 | Jan 20, 2022 |
| 424B5 | Prospectus supplement | Jan 20, 2022 | — |
| 424B5 | Prospectus supplement | Jan 18, 2022 | — |
| 6-K | Current report (foreign issuer) | Jan 14, 2022 | Sep 30, 2021 |
| S-8 | Employee stock plan registration | Aug 27, 2021 | — |
| 20-F | Annual report (foreign issuer) | Aug 13, 2021 | Mar 31, 2021 |
| NT 20-F | Notification of late filing | Aug 2, 2021 | Mar 31, 2021 |
| 6-K | Current report (foreign issuer) | May 26, 2021 | May 26, 2021 |
| 6-K | Current report (foreign issuer) | May 17, 2021 | May 17, 2021 |
| 6-K | Current report (foreign issuer) | Apr 8, 2021 | Apr 8, 2020 |
| 6-K | Current report (foreign issuer) | Mar 3, 2021 | Mar 2, 2021 |
| 6-K | Current report (foreign issuer) | Feb 16, 2021 | Feb 16, 2021 |
| EFFECT | Filing | Feb 10, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2021 | — |
| CORRESP | Letter to the SEC | Feb 9, 2021 | — |
| 6-K | Current report (foreign issuer) | Feb 3, 2021 | Feb 3, 2021 |
| F-3 | Shelf registration (foreign issuer) | Feb 2, 2021 | — |
| 6-K | Current report (foreign issuer) | Jan 28, 2021 | Sep 30, 2020 |
| 6-K | Current report (foreign issuer) | Dec 3, 2020 | Dec 1, 2020 |
| 20-F | Annual report (foreign issuer) | Jul 31, 2020 | Mar 31, 2020 |
| 6-K | Current report (foreign issuer) | Jul 10, 2020 | Jul 10, 2020 |
| 6-K/A | Amendment to report of foreign private issuer | May 22, 2020 | Sep 30, 2019 |
| 6-K | Current report (foreign issuer) | Apr 22, 2020 | Sep 30, 2019 |
| 6-K | Current report (foreign issuer) | Mar 31, 2020 | Mar 31, 2020 |
| 6-K | Current report (foreign issuer) | Mar 10, 2020 | Mar 10, 2020 |
| 6-K | Current report (foreign issuer) | Mar 4, 2020 | Mar 3, 2020 |
| 6-K | Current report (foreign issuer) | Jan 31, 2020 | Jan 31, 2020 |
| 6-K | Current report (foreign issuer) | Dec 16, 2019 | Dec 16, 2019 |
| 424B8 | Prospectus | Nov 5, 2019 | — |
| 20-F/A | Amended annual report (foreign issuer) | Aug 19, 2019 | Mar 31, 2019 |
| 20-F | Annual report (foreign issuer) | Aug 15, 2019 | Mar 31, 2019 |
| 6-K | Current report (foreign issuer) | Jul 31, 2019 | Jul 31, 2019 |
| NT 20-F | Notification of late filing | Jul 31, 2019 | Mar 31, 2019 |
| EFFECT | Filing | Jun 27, 2019 | — |
| CORRESP | Letter to the SEC | Jun 25, 2019 | — |
| CORRESP | Letter to the SEC | Jun 21, 2019 | — |
| F-1/A | Amendment no.1 to form f-1 | Jun 21, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 13, 2019 | — |
| F-1 | Registration statement (foreign issuer) | May 30, 2019 | — |
| 6-K | Current report (foreign issuer) | May 3, 2019 | May 3, 2019 |
| 6-K | Current report (foreign issuer) | Apr 17, 2019 | Apr 17, 2019 |
| 6-K | Current report (foreign issuer) | Mar 28, 2019 | Mar 27, 2019 |
| 424B3 | Prospectus | Mar 5, 2019 | — |
| CERT | Filing | Jan 2, 2019 | — |
| 8-A12B | Filing | Dec 26, 2018 | — |
| 424B3 | Prospectus | Nov 14, 2018 | — |
| 424B4 | Prospectus | Oct 3, 2018 | — |
| EFFECT | Filing | Sep 28, 2018 | — |
| FWP | Free writing prospectus | Sep 27, 2018 | — |
| CORRESP | Letter to the SEC | Sep 26, 2018 | — |
| CORRESP | Letter to the SEC | Sep 26, 2018 | — |
| CORRESP | Letter to the SEC | Sep 17, 2018 | — |
| F-1/A | Filing | Sep 17, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2018 | — |
| F-1/A | Filing | Aug 17, 2018 | — |
| FWP | Free writing prospectus | Jun 7, 2018 | — |
| CORRESP | Letter to the SEC | May 7, 2018 | — |
| F-1/A | Filing | May 7, 2018 | — |
| UPLOAD | Letter from the SEC | May 1, 2018 | — |
| CORRESP | Letter to the SEC | Apr 20, 2018 | — |
| F-1/A | Filing | Apr 20, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2018 | — |
| CORRESP | Letter to the SEC | Mar 28, 2018 | — |
| F-1/A | Filing | Mar 28, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2018 | — |
| CORRESP | Letter to the SEC | Mar 6, 2018 | — |
| F-1/A | Filing | Mar 6, 2018 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2018 | — |
| F-1/A | Filing | Jan 19, 2018 | — |
| CORRESP | Letter to the SEC | Jan 19, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2018 | — |
| F-1 | Registration statement (foreign issuer) | Dec 4, 2017 | — |
Showing 139 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SXTC (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Virgin Islands, British
- Headquarters
- Taizhou
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1723980
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.